Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LLY · against 1,215 other Healthcare companies
Ranked #105 of 1,216 · scores higher than 91% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including LLY · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | LLY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,242 reported | 49.6% | 6.1% | 90% | 33% | |
| Earnings per share growthHigher is better · 677 reported | 94.6% | 9.8% | 85% | 33% | |
| 3-year revenue growthHigher is better · 1,193 reported | 39.2% | 5.8% | 91% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.0B EUR (≈$3.3B) | 100 | 99 | |
| 1 | 551M USD | 100 | 53 | |
| 1 | 658M USD | 100 | 91 | |
| 4 | 10.2B HKD (≈$1.3B) | 99 | 62 | |
| 4 | 2.1B HKD (≈$264M) | 99 | 57 | |
| 105 | 5.1B CNY (≈$712M) | 91 | 53 | |
| 105 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 170.0B HKD (≈$21.8B) |
| 91 |
| 69 |
| 105 | 1.8B USD | 91 | 52 |
| 105 | 1.5B USD | 91 | 93 |
| 105 | 1.06T USD | 91 | 63 |
| 105 | 39.5B SEK (≈$4.0B) | 91 | 53 |
| 105 | 6.1B USD | 91 | 32 |
| 105 | 484M USD | 91 | 40 |
| 105 | 322M USD | 91 | 66 |